Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

AUPH Aurinia Pharmaceuticals

7.640
+0.090+1.19%
Close 10/06 16:00 ET
High
7.790
Open
7.580
Turnover
7.65M
Low
7.510
Pre Close
7.550
Volume
1.00M
Market Cap
1.08B
P/E(TTM)
Loss
52wk High
33.972
Shares
141.89M
P/E(Static)
Loss
52wk Low
6.280
Float Cap
1.05B
Bid/Ask %
93.55%
Historical High
33.972
Shs Float
136.92M
Volume Ratio
0.59
Historical Low
1.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.56
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.73%
Amplitude
3.71%
Avg Price
7.646
Lot Size
1
Float Cap
1.05B
Bid/Ask %
93.55%
Historical High
33.972
Shs Float
136.92M
Volume Ratio
0.59
Historical Low
1.000
Dividend TTM
--
P/B
2.56
Dividend LFY
--
Turnover Ratio
0.73%
Amplitude
3.71%
Avg Price
7.646
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
CEO: Mr. Peter S. Greenleaf
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...